The deadly business of an unregulated global stem cell industry

Tamra Lysaght*, Wendy Lipworth, Tereza Hendl, Ian Kerridge, Tsung-Ling Lee, Megan Munsie, Catherine Waldby, Cameron Stewart

*Corresponding author for this work

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

In 2016, the Office of the State Coroner of New South Wales released its report into the death of an Australian woman, Sheila Drysdale, who had died from complications of an autologous stem cell procedure at a Sydney clinic. In this report, we argue that Mrs Drysdale's death was avoidable, and it was the result of a pernicious global problem of an industry exploiting regulatory systems to sell unproven and unjustified interventions with stem cells.

Original languageEnglish
Pages (from-to)744-746
Number of pages3
JournalJournal of Medical Ethics
Volume43
Issue number11
Early online date2017
DOIs
Publication statusPublished - 2017
Externally publishedYes

Fingerprint Dive into the research topics of 'The deadly business of an unregulated global stem cell industry'. Together they form a unique fingerprint.

  • Cite this

    Lysaght, T., Lipworth, W., Hendl, T., Kerridge, I., Lee, T-L., Munsie, M., ... Stewart, C. (2017). The deadly business of an unregulated global stem cell industry. Journal of Medical Ethics, 43(11), 744-746. https://doi.org/10.1136/medethics-2016-104046